CSE New Listing - Cansortium Inc. Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - March 25, 2019) - Cansortium Inc. (CSE: TIUM.U) is one of the latest new listing on the Canadian Securities Exchange. Headquartered in Miami, Florida and operating under the brand Knox Medical, the company through its subsidiaries operates 4 cultivation facilities and 11 dispensaries across Florida, Texas, Puerto Rico and Pennsylvania, with licensing pending in Michigan.

For more information, please view the InvestmentPitch Media "video" which provides additional information on the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Cansortium" in the search box. 

Cannot view this video? Visit:
http://www.investmentpitch.com/video/0_d8h9wexd/New-Listing-Cansortium-Inc-CSETIUMU

Through its wholly-owned operating subsidiary in Ontario, Canada, the company has applied for a license from Health Canada to produce dried marijuana, marijuana plants, fresh marijuana, processed oil and finished products at its property near Grimsby, Ontario and to sell such marijuana products within Canada. In Colombia, the company has obtained licenses for the cultivation, production, research and development, including the development and operation of a seed bank, domestic sales and export of medical cannabis in oil form.

Jose Hidalgo, CEO, stated: "We are excited to share this milestone with our employees and investors who have supported our vision to become a leading medical cannabis company. We are a patient-centric company, investing heavily in developing top-quality medicine and implementing cutting-edge research, while providing our customers with unparalleled care at our state-of-the-art dispensaries. We are focused on the rapid deployment of our retail operations in our home state of Florida as well as further development of the other markets in our portfolio. Our track record of achievement in every market where we operate positions us strongly for success on the Canadian Securities Exchange."

The company recently closed its IPO, raising gross proceeds of US$53,072,000 from the placement of 26,536,000 units priced at $2.00, including the over-allotment of 536,000 units, with each unit consisting of one share and one-half a warrant, with the full warrant exercisable at US$2.40 for 24 months. The units were sold by Paradigm Capital and Canaccord Genuity.

For more information, please visit the company's website www.cansortium.com, contact Jose Hidalgo, CEO, at 305-900-6266 or email jose@knoxmedical.com.

For Investor Relations contact Jeff Reath, Executive Vice-President, at 507-871-6135 or email jeff@cansortium.com

About InvestmentPitch Media

InvestmentPitch Media leverages the power of video, which together with its extensive distribution, positions a company's story ahead of the 1,000's of companies seeking awareness and funding from the financial community. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.

CONTACT: 
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/43644